In conclusion, TWEAK/Fn14 interaction leads to the progression of fibrotic liver disease via direct modulation of HSCs proliferation, making it a potential therapeutic target for liver fibrosis. The gene discussed is TNFRSF12A; the disease is Hepatic fibrosis.